Hospital
Selby General Hospital
Selby General Hospital was paid $4.05M by Medicaid between Jan 2018 and Dec 2024, across 125 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoSELBY GENERAL HOSPITAL
MARIETTA, OH 45750
MARIETTA, OH 45750
33aNPI1124073465assigned 05/24/2006
33bProvider typeCritical Access Hospital
28Total paid$4.05M
24GClaims93,260
24DCodes billed125
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#18 of 26
Median peer was paid$5.33M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,215 | $294K | |
| 2019 | 4,501 | $206K | |
| 2020 | 4,225 | $295K | |
| 2021 | 5,143 | $251K | |
| 2022 | 7,478 | $430K | |
| 2023 | 38,971 | $1.39M | |
| 2024incomplete | 26,727 | $1.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 10,326 | 9,055 | $1.10M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 5,345 | 4,422 | $579K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 2,369 | 1,872 | $336K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.0% | 928 | 643 | $282K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 744 | 615 | $214K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 4.5% | 558 | 454 | $181K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.9% | 517 | 480 | $159K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 1,313 | 1,211 | $134K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.2% | 1,154 | 993 | $131K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 284 | 247 | $78K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 222 | 194 | $72K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.7% | 417 | 207 | $70K |
113 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 780 | $70K |
| 80053 | Comprehensive metabolic panel | 1.7% | 4,683 | $70K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1.4% | 201 | $58K |
| G0378 | Hospital observation service, per hour | 1.1% | 683 | $44K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 148 | $35K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 465 | $35K |
| 94726 | <1% | 273 | $22K | |
| 97161 | <1% | 393 | $20K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,127 | $20K |
| 94010 | <1% | 145 | $17K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,021 | $17K |
| 80061 | Lipid panel | <1% | 1,193 | $17K |
| 94729 | <1% | 270 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,714 | $15K |
| 76000 | <1% | 120 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 747 | $12K |
| 71250 | <1% | 101 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 444 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,206 | $10K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,962 | $10K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,979 | $9K |
| 82962 | <1% | 1,925 | $8K | |
| 85027 | <1% | 1,059 | $7K | |
| 72141 | <1% | 28 | $7K | |
| 76536 | <1% | 60 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 408 | $7K |
| 94761 | <1% | 962 | $7K | |
| 82607 | <1% | 212 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,878 | $6K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 30 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 948 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,171 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,039 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $5K |
| 81001 | <1% | 2,557 | $5K | |
| 86850 | <1% | 176 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 723 | $4K |
| 96376 | <1% | 290 | $3K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 17 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,649 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,990 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 878 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 245 | $3K |
| 82565 | <1% | 468 | $3K | |
| 97165 | <1% | 69 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 112 | $3K |
| 72131 | <1% | 39 | $3K | |
| 86900 | <1% | 193 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 761 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,445 | $2K |
| C1776 | Joint device (implantable) | <1% | 26 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 476 | $2K |
| 94618 | <1% | 12 | $2K | |
| 94760 | <1% | 779 | $2K | |
| 86140 | <1% | 407 | $2K | |
| 83735 | <1% | 910 | $2K | |
| 85610 | <1% | 588 | $2K | |
| 85652 | <1% | 691 | $2K | |
| J3490 | Unclassified drugs | <1% | 327 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 153 | $1K |
| 73630 | <1% | 265 | $1K | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 821 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 17 | $1K |
| 87077 | <1% | 211 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,352 | $1K |
| 86901 | <1% | 191 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 167 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,996 | $1K |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 658 | $1K |
| 84484 | <1% | 713 | $1K | |
| 83690 | <1% | 718 | $1K | |
| 84439 | <1% | 49 | $983.81 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,350 | $817.83 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 905 | $586.15 |
| 87186 | <1% | 154 | $536.15 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 19 | $521.81 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 40 | $491.22 |
| 73610 | <1% | 30 | $482.36 | |
| 87070 | <1% | 57 | $404.18 | |
| 85730 | <1% | 349 | $364.19 | |
| 81025 | <1% | 518 | $346.18 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 178 | $335.09 |
| 83540 | <1% | 28 | $326.71 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 32 | $317.64 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 424 | $312.38 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,322 | $309.54 |
| 83550 | <1% | 28 | $294.66 | |
| 85379 | <1% | 94 | $282.21 | |
| 81003 | <1% | 198 | $176.79 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 376 | $166.16 |
| 83880 | <1% | 77 | $166.06 | |
| 83605 | <1% | 120 | $147.94 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 122 | $143.88 |
| 82553 | <1% | 64 | $134.27 | |
| 82150 | <1% | 48 | $123.93 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 476 | $116.95 |
| 84550 | <1% | 15 | $115.52 | |
| 82550 | <1% | 148 | $114.22 | |
| 73130 | <1% | 14 | $101.47 | |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 44 | $100.26 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 15 | $99.40 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 354 | $91.56 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 136 | $90.04 |
| 84100 | <1% | 105 | $87.92 | |
| 97116 | <1% | 18 | $81.17 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $66.00 |
| 84703 | <1% | 32 | $54.25 | |
| 87040 | <1% | 46 | $28.76 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 56 | $15.24 |
| 73562 | <1% | 13 | $12.14 | |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 96 | $2.98 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 18 | $2.16 |
| A9270 | Non-covered item or service | 0% | 398 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, PAIGE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Solutions Life Coaching Services LLC | Bowie, MD | $140K |
| Integrated Medical Clinic | Lanham, MD | $5K |
| Barbara a White MSN CRNP INC | Laurel, MD | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.